Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study
Resource Type
Article
Authors
Andreas, Pfleger (AT) ; Elise, Lammertijn (BE) ; Duška, Tješić-Drinković (HR) ; Pavel, Dřevínek (CZ) ; Milan, Macek, Jr (CZ) ; Hanne, Vebert Olesen (DK) ; Nathalie, Senecal (FR) ; Pierre-Régis, Burgel (FR) ; Godfrey, Fletcher (IE) ; Rita, Padoan (IT) ; Annalisa, Orenti (IT) ; Federico, Ambrogi (IT) ; Simone, Gambazza (IT) ; Elīna, Aleksejeva (LV) ; Anna-Maria, Charatsi (LU) ; Domenique, Zomer (NL) ; Egil, Bakkeheim (NO) ; Lukasz, Woźniacki (PL) ; Uroš, Krivec (SI) ; Christina, Krantz (SE) ; Anders, Lindblad (SE) ; Andreas, Jung (CH) ; Sarah, Clarke (UK) ; Siobhán B․, Carr (UK) ; Kim, Claire ; Higgins, Mark ; Liu, Lingyun ; Volkova, Nataliya ; Zolin, Anna ; Naehrlich, Lutz
Source
In Journal of Cystic Fibrosis May 2024 23(3):436-442
Subject
Language
ISSN
1569-1993